Blood-brain barrier carriers (L-11085, 11750, 12133, 12596, 12599, 12600) .: NR16-202/2018E-PDF
"The blood-brain barrier (BBB) is the principal hurdle in developing drugs for central nervous system (CNS) diseases such as Alzheimer’s, Parkinson’s, brain cancer, epilepsy and others. Composed of tightly adjoined endothelial cells, the BBB actively repels foreign matter from the brain; virtually no biologic molecules are able to cross it to elicit a therapeutic response. To address the need for disease-modifying CNS biologics, the NRC has developed carriers for delivering therapeutics beyond brain barriers. They can be coupled to a wide range of client molecules in order to prevent, diagnose, and treat CNS diseases"--Highlights, p. [1].
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.850877&sl=0
| Department/Agency | National Research Council Canada. |
|---|---|
| Title | Blood-brain barrier carriers (L-11085, 11750, 12133, 12596, 12599, 12600) . |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Transporteurs pour franchir la barrière hémato-encéphalique (L-11085, 11750, 12133, 12596, 12599, 12600). Caption title. "February 2018." Issued also in print format. |
| Publishing information | [Ottawa] : National Research Council Canada, 2018. |
| Description | [2] p. : col. ill. |
| ISBN | 9780660247205 |
| Catalogue number |
|
| Subject terms | Drug carriers (Pharmacy) Blood-brain barrier |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: